カテゴリー： Market Monitor Global, 世界, 医療/バイオ

STT3A抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル

◆英語タイトル：STT3A Antibody Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC12436）◆商品コード：MMG23DC12436
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月
◆ページ数：104
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のSTT3A抗体市場規模と予測を収録しています。・世界のSTT3A抗体市場：売上、2018年-2023年、2024年-2029年
・世界のSTT3A抗体市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のSTT3A抗体市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「モノクローナル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

STT3A抗体のグローバル主要企業は、Merck、 Thermo Fisher Scientific、 Proteintech Group、 LifeSpan BioSciences、 EpiGentek、 Novus Biologicals、 Affinity Biosciences、 RayBiotech、 Abbexa Ltd、 Abnova Corporation、 Leading Biology、 OriGene Technologies、 United States Biological、 Creative Biolabs、 Santa Cruz Biotechnology、 Jingjie PTM BioLab、 Biobytなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、STT3A抗体のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のSTT3A抗体市場：タイプ別、2018年-2023年、2024年-2029年
世界のSTT3A抗体市場：タイプ別市場シェア、2022年
・モノクローナル、ポリクローナル

世界のSTT3A抗体市場：用途別、2018年-2023年、2024年-2029年
世界のSTT3A抗体市場：用途別市場シェア、2022年
・免疫化学（IHC）、免疫蛍光（IF）、免疫沈降（IP）、ウェスタンブロット（WB）、ELISA、その他

世界のSTT3A抗体市場：地域・国別、2018年-2023年、2024年-2029年
世界のSTT3A抗体市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるSTT3A抗体のグローバル売上、2018年-2023年
・主要企業におけるSTT3A抗体のグローバル売上シェア、2022年
・主要企業におけるSTT3A抗体のグローバル販売量、2018年-2023年
・主要企業におけるSTT3A抗体のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Merck、 Thermo Fisher Scientific、 Proteintech Group、 LifeSpan BioSciences、 EpiGentek、 Novus Biologicals、 Affinity Biosciences、 RayBiotech、 Abbexa Ltd、 Abnova Corporation、 Leading Biology、 OriGene Technologies、 United States Biological、 Creative Biolabs、 Santa Cruz Biotechnology、 Jingjie PTM BioLab、 Biobyt

*************************************************************

・調査・分析レポートの概要
STT3A抗体市場の定義
市場セグメント
世界のSTT3A抗体市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のSTT3A抗体市場規模
世界のSTT3A抗体市場規模：2022年 VS 2029年
世界のSTT3A抗体市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのSTT3A抗体の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のSTT3A抗体製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：モノクローナル、ポリクローナル
STT3A抗体のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：免疫化学（IHC）、免疫蛍光（IF）、免疫沈降（IP）、ウェスタンブロット（WB）、ELISA、その他
STT3A抗体の用途別グローバル売上・予測

・地域別市場分析
地域別STT3A抗体市場規模 2022年と2029年
地域別STT3A抗体売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Merck、 Thermo Fisher Scientific、 Proteintech Group、 LifeSpan BioSciences、 EpiGentek、 Novus Biologicals、 Affinity Biosciences、 RayBiotech、 Abbexa Ltd、 Abnova Corporation、 Leading Biology、 OriGene Technologies、 United States Biological、 Creative Biolabs、 Santa Cruz Biotechnology、 Jingjie PTM BioLab、 Biobyt
...

This research report provides a comprehensive analysis of the STT3A Antibody market, focusing on the current trends, market dynamics, and future prospects. The report explores the global STT3A Antibody market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of STT3A Antibody, challenges faced by the industry, and potential opportunities for market players.
The global STT3A Antibody market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The STT3A Antibody market presents opportunities for various stakeholders, including Immunochemistry (IHC), Immunofluorescence (IF). Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in STT3A Antibody market. Additionally, the growing consumer demand present avenues for market expansion.
The global STT3A Antibody market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Growing patient base, launch of STT3A antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in STT3A antibody market revenue.
Key Features:
The research report on the STT3A Antibody market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the STT3A Antibody market.
Market Overview: The report provides a comprehensive overview of the STT3A Antibody market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Monoclonal, Polyclonal), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the STT3A Antibody market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the STT3A Antibody market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the STT3A Antibody market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the STT3A Antibody market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the STT3A Antibody market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the STT3A Antibody market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for STT3A Antibody, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the STT3A Antibody market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
STT3A Antibody market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Monoclonal
Polyclonal
Market segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Global STT3A Antibody Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Merck
Thermo Fisher Scientific
Proteintech Group
LifeSpan BioSciences
EpiGentek
Novus Biologicals
Affinity Biosciences
RayBiotech
Abbexa Ltd
Abnova Corporation
Leading Biology
OriGene Technologies
United States Biological
Creative Biolabs
Santa Cruz Biotechnology
Jingjie PTM BioLab
Biobyt
Outline of Major Chapters:
Chapter 1: Introduces the definition of STT3A Antibody, market overview.
Chapter 2: Global STT3A Antibody market size in revenue.
Chapter 3: Detailed analysis of STT3A Antibody company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of STT3A Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 STT3A Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global STT3A Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global STT3A Antibody Overall Market Size
2.1 Global STT3A Antibody Market Size: 2022 VS 2029
2.2 Global STT3A Antibody Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top STT3A Antibody Players in Global Market
3.2 Top Global STT3A Antibody Companies Ranked by Revenue
3.3 Global STT3A Antibody Revenue by Companies
3.4 Top 3 and Top 5 STT3A Antibody Companies in Global Market, by Revenue in 2022
3.5 Global Companies STT3A Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 STT3A Antibody Players in Global Market
3.6.1 List of Global Tier 1 STT3A Antibody Companies
3.6.2 List of Global Tier 2 and Tier 3 STT3A Antibody Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global STT3A Antibody Market Size Markets, 2022 & 2029
4.1.2 Monoclonal
4.1.3 Polyclonal
4.2 By Type – Global STT3A Antibody Revenue & Forecasts
4.2.1 By Type – Global STT3A Antibody Revenue, 2018-2023
4.2.2 By Type – Global STT3A Antibody Revenue, 2024-2029
4.2.3 By Type – Global STT3A Antibody Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global STT3A Antibody Market Size, 2022 & 2029
5.1.2 Immunochemistry (IHC)
5.1.3 Immunofluorescence (IF)
5.1.4 Immunoprecipitation (IP)
5.1.5 Western Blot (WB)
5.1.6 ELISA
5.1.7 Others
5.2 By Application – Global STT3A Antibody Revenue & Forecasts
5.2.1 By Application – Global STT3A Antibody Revenue, 2018-2023
5.2.2 By Application – Global STT3A Antibody Revenue, 2024-2029
5.2.3 By Application – Global STT3A Antibody Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global STT3A Antibody Market Size, 2022 & 2029
6.2 By Region – Global STT3A Antibody Revenue & Forecasts
6.2.1 By Region – Global STT3A Antibody Revenue, 2018-2023
6.2.2 By Region – Global STT3A Antibody Revenue, 2024-2029
6.2.3 By Region – Global STT3A Antibody Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America STT3A Antibody Revenue, 2018-2029
6.3.2 US STT3A Antibody Market Size, 2018-2029
6.3.3 Canada STT3A Antibody Market Size, 2018-2029
6.3.4 Mexico STT3A Antibody Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe STT3A Antibody Revenue, 2018-2029
6.4.2 Germany STT3A Antibody Market Size, 2018-2029
6.4.3 France STT3A Antibody Market Size, 2018-2029
6.4.4 U.K. STT3A Antibody Market Size, 2018-2029
6.4.5 Italy STT3A Antibody Market Size, 2018-2029
6.4.6 Russia STT3A Antibody Market Size, 2018-2029
6.4.7 Nordic Countries STT3A Antibody Market Size, 2018-2029
6.4.8 Benelux STT3A Antibody Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia STT3A Antibody Revenue, 2018-2029
6.5.2 China STT3A Antibody Market Size, 2018-2029
6.5.3 Japan STT3A Antibody Market Size, 2018-2029
6.5.4 South Korea STT3A Antibody Market Size, 2018-2029
6.5.5 Southeast Asia STT3A Antibody Market Size, 2018-2029
6.5.6 India STT3A Antibody Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America STT3A Antibody Revenue, 2018-2029
6.6.2 Brazil STT3A Antibody Market Size, 2018-2029
6.6.3 Argentina STT3A Antibody Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa STT3A Antibody Revenue, 2018-2029
6.7.2 Turkey STT3A Antibody Market Size, 2018-2029
6.7.3 Israel STT3A Antibody Market Size, 2018-2029
6.7.4 Saudi Arabia STT3A Antibody Market Size, 2018-2029
6.7.5 UAE STT3A Antibody Market Size, 2018-2029
7 STT3A Antibody Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck STT3A Antibody Major Product Offerings
7.1.4 Merck STT3A Antibody Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific STT3A Antibody Major Product Offerings
7.2.4 Thermo Fisher Scientific STT3A Antibody Revenue in Global Market (2018-2023)
7.2.5 Thermo Fisher Scientific Key News & Latest Developments
7.3 Proteintech Group
7.3.1 Proteintech Group Company Summary
7.3.2 Proteintech Group Business Overview
7.3.3 Proteintech Group STT3A Antibody Major Product Offerings
7.3.4 Proteintech Group STT3A Antibody Revenue in Global Market (2018-2023)
7.3.5 Proteintech Group Key News & Latest Developments
7.4 LifeSpan BioSciences
7.4.1 LifeSpan BioSciences Company Summary
7.4.2 LifeSpan BioSciences Business Overview
7.4.3 LifeSpan BioSciences STT3A Antibody Major Product Offerings
7.4.4 LifeSpan BioSciences STT3A Antibody Revenue in Global Market (2018-2023)
7.4.5 LifeSpan BioSciences Key News & Latest Developments
7.5 EpiGentek
7.5.1 EpiGentek Company Summary
7.5.2 EpiGentek Business Overview
7.5.3 EpiGentek STT3A Antibody Major Product Offerings
7.5.4 EpiGentek STT3A Antibody Revenue in Global Market (2018-2023)
7.5.5 EpiGentek Key News & Latest Developments
7.6 Novus Biologicals
7.6.1 Novus Biologicals Company Summary
7.6.2 Novus Biologicals Business Overview
7.6.3 Novus Biologicals STT3A Antibody Major Product Offerings
7.6.4 Novus Biologicals STT3A Antibody Revenue in Global Market (2018-2023)
7.6.5 Novus Biologicals Key News & Latest Developments
7.7 Affinity Biosciences
7.7.1 Affinity Biosciences Company Summary
7.7.2 Affinity Biosciences Business Overview
7.7.3 Affinity Biosciences STT3A Antibody Major Product Offerings
7.7.4 Affinity Biosciences STT3A Antibody Revenue in Global Market (2018-2023)
7.7.5 Affinity Biosciences Key News & Latest Developments
7.8 RayBiotech
7.8.1 RayBiotech Company Summary
7.8.2 RayBiotech Business Overview
7.8.3 RayBiotech STT3A Antibody Major Product Offerings
7.8.4 RayBiotech STT3A Antibody Revenue in Global Market (2018-2023)
7.8.5 RayBiotech Key News & Latest Developments
7.9 Abbexa Ltd
7.9.1 Abbexa Ltd Company Summary
7.9.2 Abbexa Ltd Business Overview
7.9.3 Abbexa Ltd STT3A Antibody Major Product Offerings
7.9.4 Abbexa Ltd STT3A Antibody Revenue in Global Market (2018-2023)
7.9.5 Abbexa Ltd Key News & Latest Developments
7.10 Abnova Corporation
7.10.1 Abnova Corporation Company Summary
7.10.2 Abnova Corporation Business Overview
7.10.3 Abnova Corporation STT3A Antibody Major Product Offerings
7.10.4 Abnova Corporation STT3A Antibody Revenue in Global Market (2018-2023)
7.10.5 Abnova Corporation Key News & Latest Developments
7.11 Leading Biology
7.11.1 Leading Biology Company Summary
7.11.2 Leading Biology Business Overview
7.11.3 Leading Biology STT3A Antibody Major Product Offerings
7.11.4 Leading Biology STT3A Antibody Revenue in Global Market (2018-2023)
7.11.5 Leading Biology Key News & Latest Developments
7.12 OriGene Technologies
7.12.1 OriGene Technologies Company Summary
7.12.2 OriGene Technologies Business Overview
7.12.3 OriGene Technologies STT3A Antibody Major Product Offerings
7.12.4 OriGene Technologies STT3A Antibody Revenue in Global Market (2018-2023)
7.12.5 OriGene Technologies Key News & Latest Developments
7.13 United States Biological
7.13.1 United States Biological Company Summary
7.13.2 United States Biological Business Overview
7.13.3 United States Biological STT3A Antibody Major Product Offerings
7.13.4 United States Biological STT3A Antibody Revenue in Global Market (2018-2023)
7.13.5 United States Biological Key News & Latest Developments
7.14 Creative Biolabs
7.14.1 Creative Biolabs Company Summary
7.14.2 Creative Biolabs Business Overview
7.14.3 Creative Biolabs STT3A Antibody Major Product Offerings
7.14.4 Creative Biolabs STT3A Antibody Revenue in Global Market (2018-2023)
7.14.5 Creative Biolabs Key News & Latest Developments
7.15 Santa Cruz Biotechnology
7.15.1 Santa Cruz Biotechnology Company Summary
7.15.2 Santa Cruz Biotechnology Business Overview
7.15.3 Santa Cruz Biotechnology STT3A Antibody Major Product Offerings
7.15.4 Santa Cruz Biotechnology STT3A Antibody Revenue in Global Market (2018-2023)
7.15.5 Santa Cruz Biotechnology Key News & Latest Developments
7.16 Jingjie PTM BioLab
7.16.1 Jingjie PTM BioLab Company Summary
7.16.2 Jingjie PTM BioLab Business Overview
7.16.3 Jingjie PTM BioLab STT3A Antibody Major Product Offerings
7.16.4 Jingjie PTM BioLab STT3A Antibody Revenue in Global Market (2018-2023)
7.16.5 Jingjie PTM BioLab Key News & Latest Developments
7.17 Biobyt
7.17.1 Biobyt Company Summary
7.17.2 Biobyt Business Overview
7.17.3 Biobyt STT3A Antibody Major Product Offerings
7.17.4 Biobyt STT3A Antibody Revenue in Global Market (2018-2023)
7.17.5 Biobyt Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ STT3A抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル(STT3A Antibody Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ENO3抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • 抗R1抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • CD115抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • CD55抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • ME2抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル